Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist. [electronic resource]
- International journal of molecular sciences Feb 2020
Publication Type: Journal Article
1422-0067
10.3390/ijms21041444 doi
Benzoates--pharmacology Bone Morphogenetic Protein 4--metabolism Chondrogenesis--drug effects Humans Mesenchymal Stem Cells--metabolism Receptors, Retinoic Acid--agonists Stilbenes--pharmacology